Cargando…

Writers Are Common among Parkinson's Disease Patients: A Longitudinal Study

Parkinson's disease (PD) patients may have a specific personality profile, which includes being introvert, cautious and devoted to hard work. The evaluation of psychological characteristics must be evaluated according to methods for assessments of personality disorders. Such evaluations are oft...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aasly, Anna, Aasly, Jan O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121563/ https://www.ncbi.nlm.nih.gov/pubmed/34035867 http://dx.doi.org/10.1155/2021/5559926

Ejemplares similares

Long-Term Outcomes of Genetic Parkinson’s Disease
por: Aasly, Jan O.
Publicado: (2020)

Clinical and Imaging Markers of Prodromal Parkinson's Disease
por: Hustad, Eldbjørg, et al.
Publicado: (2020)

Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease
por: Warø, Bjørg Johanne, et al.
Publicado: (2017)

Genetic association study of synphilin-1 in idiopathic Parkinson's disease
por: Myhre, Ronny, et al.
Publicado: (2008)

The accuracy of the clinical diagnosis of Parkinson disease. The HUNT study
por: Hustad, Eldbjørg, et al.
Publicado: (2018)

Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort
por: Aasly, Jan O.
Publicado: (2021)

Increased Mortality in Young-Onset Parkinson’s Disease
por: Hustad, Eldbjørg, et al.
Publicado: (2021)

What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?
por: Loeffler, David A., et al.
Publicado: (2019)

Combining clinical and biofluid markers for early Parkinson's disease detection
por: Yu, Zhenwei, et al.
Publicado: (2017)

Bilateral Optic Neuritis Associated with the Use of Infliximab
por: Aasly, Jan O.
Publicado: (2011)

GBA1 in Parkinson’s disease: variant detection and pathogenicity scoring matters
por: Gabbert, Carolin, et al.
Publicado: (2023)

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage
por: Majbour, Nour, et al.
Publicado: (2022)

A Case of Parkinson's Disease with No Lewy Body Pathology due to a Homozygous Exon Deletion in Parkin
por: Johansen, Krisztina Kunszt, et al.
Publicado: (2018)

Metabolomic Profiling in LRRK2-Related Parkinson's Disease
por: Johansen, Krisztina K., et al.
Publicado: (2009)

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy
por: Aasly, Jan O., et al.
Publicado: (2015)

Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson’s Disease: A Pilot Study
por: Yilmaz, Ali, et al.
Publicado: (2020)

Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson’s Disease-Associated LRRK2 Gene Mutations
por: Loeffler, David A., et al.
Publicado: (2017)

The Incidence of Diagnosis of Munchausen Syndrome, Other Factitious Disorders, and Malingering
por: Schrader, Harald, et al.
Publicado: (2019)

Longitudinal Monitoring of Parkinson's Disease in Different Ethnic Cohorts: The DodoNA and LONG-PD Study
por: Markopoulou, Katerina, et al.
Publicado: (2020)

Theoretical temperature model with experimental validation for CLIC Accelerating Structures
por: Aasly, Sara Hegdahl
Publicado: (2017)

Incidence of the diagnosis of factitious disorders – Nationwide comparison study between Germany and Norway
por: Geile, Julian, et al.
Publicado: (2020)

Ataxia with Vitamin E Deficiency in Norway
por: Elkamil, Areej, et al.
Publicado: (2015)

Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient?
por: Johansen, Krisztina K., et al.
Publicado: (2013)

3α,7-Dihydroxy-14(13→12)abeo-5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson’s Disease
por: Luxenburger, Andreas, et al.
Publicado: (2022)

Factitious disorders in Germany–a detailed insight
por: Prangenberg, Julian, et al.
Publicado: (2021)

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
por: Majbour, Nour K., et al.
Publicado: (2020)

Cerebrospinal Fluid Concentration of Key Autophagy Protein Lamp2 Changes Little During Normal Aging
por: Loeffler, David A., et al.
Publicado: (2018)

Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study
por: Chase, Bruce A., et al.
Publicado: (2023)

Writers' Diabetes
Publicado: (1897)

The Type Writer
Publicado: (1874)

Responsibility of Writers
Publicado: (1878)

Writer’s Cramp
Publicado: (1886)

APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway
por: Sando, Sigrid B, et al.
Publicado: (2008)

Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
por: Stewart, Tessandra, et al.
Publicado: (2015)

Keys for writers
por: Raimes, Ann, 1938-
Publicado: (2005)

Writers' theatre /
por: Waterhouse, Keith
Publicado: (1967)

The writer's handbook /
Publicado: (1998)

The writer's eye
por: Leavitt, Hart Day
Publicado: (1968)

The writer's handbook /
Publicado: (1970)

The versatile writer
por: Stewart, Donald C.
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_ee6enkq092fapdid2cie7m367n